Paradoxical Procoagulant Effect of Early Doses of Warfarin: Possible Role of Non-Vitamin K Oral Anticoagulant in Patients with Atrial Fibrillation-Related Stroke
Yesel Kim, Oh Young Bang
J Stroke. 2015;17(2):216-218.   Published online 2015 May 29     DOI: https://doi.org/10.5853/jos.2015.17.2.216
Citations to this article as recorded by Crossref logo
An insight into the therapeutic applications of coumarin compounds and their mechanisms of action
Sourbh Suren Garg, Jeena Gupta, Shikha Sharma, Debasis Sahu
European Journal of Pharmaceutical Sciences.2020; 152: 105424.     CrossRef
Atrial fibrillation and thrombophilia. DOAC as a valid alternative? A clinical case
Claudia Morabito, Matteo Casale, Pasquale Crea, Silvia Morabito, Luca Zappia, Roberto Licordari, Nunzio Antonio Giovanni Fichera, Arianna D'Angelo, Alessandro Migliorato, Francesco Luzza, Giuseppe Dattilo
Cor et Vasa.2020; 62(5): 470.     CrossRef
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting
Jordan L Lacoste, Cory L Hansen
American Journal of Health-System Pharmacy.2019; 76(18): 1395.     CrossRef
Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
Michele Scarano, Matteo Casale, Cesare Mantini, Egidio Imbalzano, Cristiana Consorti, Daniela Clemente, Giuseppe Dattilo
Journal of Medical Case Reports.2017;[Epub]     CrossRef
Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants
Oh Young Bang, Keun-Sik Hong, Ji Hoe Heo
Journal of Stroke.2016; 18(2): 169.     CrossRef
Dabigatran Effect on Left Ventricular Thrombus in a Patient with Acute Ischemic Stroke
Kyuyoon Chung, Young Min Paek, Hye Jung Lee, Keun-Sik Hong
Journal of Stroke.2015; 17(3): 366.     CrossRef